Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Antibodies
Biosimilars
Proteins
Immunotherapy
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Respiratory / pulmonology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Description:
Harbour BioMed is a global biotechnology company focused on the discovery and development of innovative therapeutics for cancer and inflammatory diseases, with an emphasis on immuno-oncology. Established with an initial investment of USD 50 million, the company acquired Harbour Antibodies BV in Rotterdam, gaining access to two proprietary transgenic mouse platforms (Harbour Mice®) for generating fully human monoclonal antibodies and heavy chain–only antibodies. Its discovery and development...
